Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: BMI differences among in-hospital management and outcomes in patients with atrial fibrillation: findings from the Care for Cardiovascular Disease project in China

Fig. 1

Medication and intervention therapies in hospitalization (a) and discharge (b) respectively according to BMI stratification. Ab indicates ablation; Pi, Pacemaker implantation; Cv, Cardioversion; β, beta-blocker; CCB, Calcium channel blocker; Aa, Antiarrhythmic agents; Ap, Antiplatelet agents; Wa, Warfarin; As, Aspirin. ** p < 0.01 among groups. † Treatment of calcium channel blocker included Dihydroarsenidine and non-Dihydroarsenidine. †† Treatment of cardioversion included drug and electrical cardioversion

Back to article page